Clinical Trials
2 trialsNCT05718219 2025-08-13
Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of SIM0348 in Advanced Solid Tumors
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 1 Active not recruiting
NCT04220944 2024-08-01
Combined Locoregional Treatment With Immunotherapy for Unresectable HCC.
Shanghai Zhongshan Hospital
Phase 1 Active not recruiting